Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
10.1245/ASO.2005.04.003
Annals of Surgical Oncology 12:161-166 (2005)
© 2005 Society of Surgical Oncology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gouy, S.
Right arrow Articles by Barreau-Pouhaer, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gouy, S.
Right arrow Articles by Barreau-Pouhaer, L.

Original Article

Immediate Reconstruction After Neoadjuvant Chemotherapy: Effect on Adjuvant Treatment Starting and Survival

Sebastien Gouy, MD1, Roman Rouzier, MD1,2, Marie-Christine Missana, MD1, David Atallah, MD3, Omar Youssef, MD4 and Lise Barreau-Pouhaer, MD1

1 Breast Surgery Unit, Institut Gustave-Roussy, 39 Rue C. Desmoulins, 94805 Villejuif Cedex, France
2 Department of Breast Medical Oncology, University of Texas M. D. Anderson Cancer Center, Box 424, 1515 Holcombe Boulevard, Houston, Texas 77030
3 Department of Gynaecologic Surgery, Hotel-Dieu, PO Box 16-6830, Beirut, Lebanon
4 Department of Surgical Oncology, National Cancer Institute, Cairo, Egypt

Correspondence: Address correspondence and reprint requests to: Roman Rouzier, MD; E-mail: rrouzier{at}mdanderson.org.

Background: For patients treated with initial surgery, the safety of immediate breast reconstruction after mastectomy has been demonstrated. Some concerns exist after neoadjuvant chemotherapy because this sequence is proposed for patients with large tumors and for whom adjuvant therapies are considered cornerstones of treatment. In this study, we sought to determine whether reconstruction after neoadjuvant chemotherapy and mastectomy for large operable breast cancer affects the interval between surgery and adjuvant treatment and affects survival.

Methods: A single-institution retrospective analysis was performed by using the database of the Institut Gustave-Roussy.

Results: Forty-eight patients who had undergone mastectomy and immediate reconstruction (implant, 60%) followed by adjuvant chemotherapy were identified. They were compared with 181 patients who underwent mastectomy without reconstruction and with 32 patients who underwent mastectomy followed by delayed reconstruction (implant, 19%). No difference was found concerning the interval between surgery and adjuvant chemotherapy: 26 vs. 23 days for patients with immediate breast reconstruction and for patients treated with modified radical mastectomy followed or not by delayed reconstruction, respectively (P = .11). No difference was found concerning the onset of radiotherapy: 87 vs. 81 days (P = .22). Survival was not different in patients treated with immediate reconstruction compared with those with mastectomy alone.

Conclusions: Immediate breast reconstruction does not delay the starting of adjuvant therapy and has no significant effect on local relapse–free or distant disease–free survival. Additional data are needed concerning the use of flap for this indication.

Key Words: Breast cancer • Neoadjuvant chemotherapy • Immediate reconstruction • Survival






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Society of Surgical Oncology.